Warner Bros. Discovery, Inc.
Pyridone-Pyrimidine Derivative Acting As KRASG12C Mutein Inhibitor

Last updated:

Abstract:

Provided are a class of KRAS G12C mutein inhibitors, which relate in particular to a compound represented by formula (I), an isomer thereof, and a pharmaceutically acceptable salt thereof. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

27 Jan 2021

Issue date:

20 May 2021